Literature DB >> 25438871

Risk of the development of Type 2 diabetes in relation to overall obesity, abdominal obesity and the clustering of metabolic abnormalities in Japanese individuals: does metabolically healthy overweight really exist? The Niigata Wellness Study.

Y Heianza1, K Kato, S Kodama, N Ohara, A Suzuki, S Tanaka, O Hanyu, K Sato, H Sone.   

Abstract

AIMS: We investigated the risk of developing diabetes across various metabolic phenotypes by considering the presence of overall adiposity or abdominal adiposity and the number of metabolic abnormalities and aimed to clarify whether a 'healthy overweight' phenotype, that is, overweight with no metabolic abnormalities, was protective of the development of diabetes.
METHODS: We studied 29 564 Japanese individuals without diabetes. The 5-year incidence of diabetes was assessed according to a combination of either overweight (BMI ≥ 25.0 kg/m(2) ) or abdominal obesity (waist circumference ≥ 90 cm in men and ≥ 80 cm in women) and the number of metabolic factors present (hypertension, elevated triglyceride concentration, low HDL cholesterol concentration and impaired fasting glucose).
RESULTS: A total of 1188 individuals developed diabetes. Compared with normal weight individuals with none of the four metabolic abnormalities, in overweight individuals with none of the four abnormalities there was an odds ratio (OR) of 2.32 [95% confidence interval (CI) 1.50, 3.59] for diabetes; having any one metabolic abnormality increased the risk of developing diabetes among normal weight individuals [OR 3.23 (2.55, 4.10)] and overweight individuals [OR 5.00 (3.77, 6.63)]. Among overweight individuals, the presence of impaired fasting glucose alone substantially elevated the risk of diabetes by 8.98-fold (5.52, 14.6) in comparison with the absence of the four metabolic factors.
CONCLUSIONS: Being 'healthy overweight' was associated with a higher OR of developing future diabetes among Japanese individuals than normal weight individuals with no metabolic abnormalities, and being overweight with one or more abnormalities had a further elevated OR compared with 'healthy overweight' people.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25438871     DOI: 10.1111/dme.12646

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  Skinfold thickness and the incidence of type 2 diabetes mellitus and hypertension: an analysis of the PERU MIGRANT study.

Authors:  Andrea Ruiz-Alejos; Rodrigo M Carrillo-Larco; J Jaime Miranda; Robert H Gilman; Liam Smeeth; Antonio Bernabé-Ortiz
Journal:  Public Health Nutr       Date:  2019-06-04       Impact factor: 4.022

2.  Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.

Authors:  R Dobson; M I Burgess; V S Sprung; A Irwin; M Hamer; J Jones; C Daousi; V Adams; G J Kemp; F Shojaee-Moradie; M Umpleby; D J Cuthbertson
Journal:  Int J Obes (Lond)       Date:  2015-08-14       Impact factor: 5.095

3.  Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia.

Authors:  L de Abreu; Kara L Holloway; Mark A Kotowicz; Julie A Pasco
Journal:  J Diabetes Res       Date:  2015-07-27       Impact factor: 4.011

4.  Correlates of and Body Composition Measures Associated with Metabolically Healthy Obesity Phenotype in Hispanic/Latino Women and Men: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Mayra L Estrella; Amber Pirzada; Ramon A Durazo-Arvizu; Jianwen Cai; Aida L Giachello; Rebeca Espinoza Gacinto; Anna Maria Siega-Riz; Martha L Daviglus
Journal:  J Obes       Date:  2019-01-15

5.  Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome.

Authors:  Fayaz Ahmad Mir; Raghvendra Mall; Ahmad Iskandarani; Ehsan Ullah; Tareq A Samra; Farhan Cyprian; Aijaz Parray; Meis Alkasem; Ibrahem Abdalhakam; Faisal Farooq; Abdul-Badi Abou-Samra
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

6.  Impact of individual components and their combinations within a family history of hypertension on the incidence of hypertension: Toranomon hospital health management center study 22.

Authors:  Risa Igarashi; Kazuya Fujihara; Yoriko Heianza; Masahiro Ishizawa; Satoru Kodama; Kazumi Saito; Shigeko Hara; Osamu Hanyu; Ritsuko Honda; Hiroshi Tsuji; Yasuji Arase; Hirohito Sone
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Metabolic Health Has Greater Impact on Diabetes than Simple Overweight/Obesity in Mexican Americans.

Authors:  Shenghui Wu; Susan P Fisher-Hoch; Belinda Reninger; Kristina Vatcheva; Joseph B McCormick
Journal:  J Diabetes Res       Date:  2016-01-10       Impact factor: 4.011

8.  IMPACT OF OBESITY AND SURGICAL SKILLS IN LAPAROSCOPIC TOTALLY EXTRAPERITONEAL HERNIOPLASTY.

Authors:  Juliana Mika Kato; Leandro Ryuchi Iuamoto; Fábio Yuji Suguita; Felipe Futema Essu; Alberto Meyer; Wellington Andraus
Journal:  Arq Bras Cir Dig       Date:  2017 Jul-Sep

9.  Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.

Authors:  Kayo Kurotani; Toshiaki Miyamoto; Takeshi Kochi; Masafumi Eguchi; Teppei Imai; Akiko Nishihara; Kentaro Tomita; Akihiko Uehara; Makoto Yamamoto; Taizo Murakami; Chii Shimizu; Makiko Shimizu; Satsue Nagahama; Tohru Nakagawa; Toru Honda; Shuichiro Yamamoto; Hiroko Okazaki; Naoko Sasaki; Ai Hori; Chihiro Nishiura; Keisuke Kuwahara; Reiko Kuroda; Shamima Akter; Ikuko Kashino; Akiko Nanri; Isamu Kabe; Tetsuya Mizoue; Naoki Kunugita; Seitaro Dohi
Journal:  J Epidemiol       Date:  2017-04-20       Impact factor: 3.211

10.  Mexican American and South Asian population-based cohorts reveal high prevalence of type 2 diabetes and crucial differences in metabolic phenotypes.

Authors:  Gordon P Watt; Susan P Fisher-Hoch; Mohammad H Rahbar; Joseph B McCormick; Miryoung Lee; Audrey C Choh; Sadagopan Thanikachalam; Mohan Thanikachalam
Journal:  BMJ Open Diabetes Res Care       Date:  2018-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.